BioCentury
ARTICLE | Clinical News

Apokyn apomorphine injection regulatory update

April 26, 2004 7:00 AM UTC

FDA granted marketing approval to MYL's Bertek Pharmaceuticals Inc. subsidiary (Research Triangle Park, N.C.) for its Apokyn to treat "off" episodes associated with Parkinson's disease (PD). MYL expec...